Kelso Pharma appoints new CFO
Kelso Pharma, the high-growth specialty pharmaceuticals business, announces that Allan Watson, the company’s Chief Financial Officer, has decided to retire from his role and is being succeeded by life sciences financial specialist, Alan King. Apposite Capital-backed Kelso Pharma is focused on bringing innovative, value-added, specialty medicines to international healthcare markets, providing products that improve the […]